InSphero Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 110

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 13

  • Investments
  • 3

InSphero General Information

Description

Developer of cell-based assay and scaffold-free organoid, spheroid, and organ-on-a-chip technology designed to provide biologically relevant insights for in vitro testing. The company offers predictive preclinical testing platforms and three-dimensional cell culture technologies for biotechnology and pharmaceutical companies, enabling them to identify drug efficacy and toxic liabilities, reduce development costs, shorten development timelines, and minimize animal testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Wagistrasse 27A
  • 8952 Schlieren
  • Switzerland
+41 044
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Wagistrasse 27A
  • 8952 Schlieren
  • Switzerland
+41 044

InSphero Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InSphero Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InSphero‘s full profile, request access.

Request a free trial

InSphero Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell-based assay and scaffold-free organoid, spheroid, and organ-on-a-chip technology designed to provide b
Biotechnology
Schlieren, Switzerland
110 As of 2026

Hayward, CA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InSphero Competitors (27)

One of InSphero’s 27 competitors is Frontier Bio, a Venture Capital-Backed company based in Hayward, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Frontier Bio Venture Capital-Backed Hayward, CA
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Ncardia Venture Capital-Backed Leiden, Netherlands
Hesperos Venture Capital-Backed Orlando, FL
28bio Venture Capital-Backed New Orleans, LA
You’re viewing 5 of 27 competitors. Get the full list »

InSphero Patents

InSphero Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4788786-A1 Device for studying interactions of biological specimen Pending 06-Oct-2023
WO-2025073379-A1 Device for studying interactions of biological specimen Inactive 06-Oct-2023
EP-4608134-A1 System for freezing and/or vitrifying biological specimen Pending 26-Oct-2022
US-20260334463-A1 System for freezing and/or vitrifying biological specimen Pending 26-Oct-2022
WO-2024089184-A1 System for freezing and/or vitrifying biological specimen Inactive 26-Oct-2022 A01N1/145
To view InSphero’s complete patent history, request access »

InSphero Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InSphero Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore InSphero‘s full profile, request access.

Request a free trial

InSphero Acquisitions (3)

InSphero’s most recent deal was a Merger/Acquisition with PhenoVista. The deal was made on 20-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PhenoVista 20-May-2026 Merger/Acquisition Other Pharmaceuticals and Biotechnology
SUN bioscience 17-Nov-2025 Merger/Acquisition Discovery Tools (Healthcare)
Doppl 11-Nov-2025 Merger/Acquisition Drug Discovery
To view InSphero’s complete acquisitions history, request access »

InSphero Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
PhenoVista San Diego, CA 2014

InSphero FAQs

  • When was InSphero founded?

    InSphero was founded in 2009.

  • Where is InSphero headquartered?

    InSphero is headquartered in Schlieren, Switzerland.

  • What is the size of InSphero?

    InSphero has 110 total employees.

  • What industry is InSphero in?

    InSphero’s primary industry is Biotechnology.

  • Is InSphero a private or public company?

    InSphero is a Private company.

  • What is InSphero’s current revenue?

    The current revenue for InSphero is .

  • How much funding has InSphero raised over time?

    InSphero has raised $63.4M.

  • Who are InSphero’s investors?

    BroadOak Capital Partners, , SICTIC, ZEISS Ventures, and are 5 of 9 investors who have invested in InSphero.

  • Who are InSphero’s competitors?

    Frontier Bio, Aspect Biosystems, Ncardia, Hesperos, and 28bio are some of the 27 competitors of InSphero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process